Internal Medicine, Hematology & Oncology · Grand Rapids, MI
NPI
1568641074
Since 2007
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
5800 Foremost Dr SE Ste 200
Grand Rapids, MI, 49546
Phone (616) 389-1800
Groups this clinician bills Medicare through
Medicare paid, 2024
$361K
26,859 services
Medicare patients, 2024
335
Average age 71
Drug cost, 2024
$1.1M
714 prescriptions
Company payments, 2025
$257
From 8 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Frances Y Wong was code J1437 (injection, ferric derisomaltose, 10 mg), 1,100 times for 11 patients. In total Frances Y Wong billed 26,859 services in 113 codes, and Medicare paid $361K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-03-17.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1437 Injection, ferric derisomaltose, 10 mg | Office | 1,100 | 11 | $16.28 | $18K |
| 36415 Venipuncture Blood Collection | Office | 476 | 133 | $8.48 | $4,037 |
| 85025 Blood Count | Office | 468 | 129 | $7.46 | $3,491 |
| 80053 Clinical Chemistry | Office | 128 | 73 | $10.29 | $1,317 |
| 99223 Hospital E&M - Initial | Facility | 127 | 117 | $130.61 | $17K |
| 82728 Clinical Chemistry | Office | 101 | 65 | $13.03 | $1,316 |
| 83540 Clinical Chemistry | Office | 87 | 55 | $6.22 | $541 |
| 84466 Clinical Chemistry | Office | 86 | 53 | $12.15 | $1,045 |
| 99214 Office E&M - Established | Office | 85 | 64 | $78.18 | $6,645 |
| 96372 Injection Administration | Office | 78 | 24 | $10.21 | $797 |
| 99215 Office E&M - Established | Office | 73 | 61 | $115.14 | $8,405 |
| 82607 Clinical Chemistry | Office | 62 | 41 | $14.59 | $905 |
| 82746 Clinical Chemistry | Office | 60 | 40 | $14.22 | $853 |
| 99233 Hospital E&M - Subsequent | Facility | 49 | 37 | $87.44 | $4,285 |
| 99232 Hospital E&M - Subsequent | Facility | 43 | 29 | $60.04 | $2,582 |
By year: 2022 $306K for 45,729 services; 2023 $309K for 42,771 services; 2024 $361K for 26,859 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 476 | 133 | $8.48 | $4,037 |
| 85025 Blood Count | 468 | 129 | $7.46 | $3,491 |
| 80053 Clinical Chemistry | 128 | 73 | $10.29 | $1,317 |
| 82728 Clinical Chemistry | 101 | 65 | $13.03 | $1,316 |
| 83540 Clinical Chemistry | 87 | 55 | $6.22 | $541 |
| 84466 Clinical Chemistry | 86 | 53 | $12.15 | $1,045 |
| 82607 Clinical Chemistry | 62 | 41 | $14.59 | $905 |
| 82746 Clinical Chemistry | 60 | 40 | $14.22 | $853 |
| 83521 Immunoassay | 30 | 14 | $16.93 | $508 |
| 85046 Blood Count | 18 | 17 | $5.46 | $98.28 |
Medicare prescription drug claims, 2024
In 2024, the drug Frances Y Wong prescribed most often to Medicare patients was Hydroxyurea, with 208 prescriptions and refills. In total Frances Y Wong wrote 714 Medicare prescriptions that cost $1.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Hydroxyurea Generic | 208 | 347 | 41 | $4,676 |
| Eliquis Apixaban | 124 | 187 | 21 | $99K |
| Prednisone Generic | 75 | 92 | 17 | $402 |
| Xarelto Rivaroxaban | 55 | 85 | Under 11 | $45K |
| Anagrelide Hcl Generic | 49 | 67 | Under 11 | $4,348 |
| Oxycodone Hcl Generic | 19 | 19 | Under 11 | $257 |
| Folic Acid Generic | 17 | 25 | Under 11 | $48.76 |
| Promacta Eltrombopag Olamine | 17 | 17 | Under 11 | $130K |
| Sirolimus Generic | 16 | 16 | Under 11 | $2,714 |
| Warfarin Sodium Generic | 15 | 47 | Under 11 | $91.2 |
| Jakafi Ruxolitinib Phosphate | 12 | 12 | Under 11 | $194K |
| Ferriprox (2 Times A Day) Deferiprone | 11 | 11 | Under 11 | $575K |
Brand drugs: 229 claims; generic drugs: 485 claims; opioid claims: 21.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Frances Y Wong $257 ($257 in general payments such as food, travel and fees) from 8 companies. The largest payer was Novartis Pharmaceuticals Corporation with $105.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.